Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 53
1996 64
1997 59
1998 71
1999 51
2000 59
2001 69
2002 72
2003 71
2004 168
2005 200
2006 179
2007 250
2008 407
2009 297
2010 486
2011 623
2012 306
2013 425
2014 297
2015 356
2016 373
2017 337
2018 289
2019 343
2020 342
2021 331
2022 338
2023 422
2024 141

Text availability

Article attribute

Article type

Publication date

Search Results

7,119 results

Results by year

Filters applied: . Clear all
Page 1
Real-World Evidence of Effectiveness and Safety of Vedolizumab for Inflammatory Bowel Disease in Taiwan: A Prospective Nationwide Registry (VIOLET) Study.
Lin WC, Tai WC, Chang CH, Tu CH, Feng IC, Shieh MJ, Chung CS, Yen HH, Chou JW, Wong JM, Liu YH, Huang TY, Chuang CH, Tsai TJ, Chiang FF, Lu CY, Hsu WH, Yu FJ, Chao TH, Wu DC, Ho AS, Lin HH, Feng CL, Wu KL, Wong MW, Tung CC, Lin CC, Chen CC, Hu HM, Lu LS, Wang HS, Wu IC, Kuo HY, Wu JF, Yao Shih H, Ni YH, Tang SL, Chen PH, Wei SC. Lin WC, et al. Inflamm Bowel Dis. 2023 Nov 2;29(11):1730-1740. doi: 10.1093/ibd/izac269. Inflamm Bowel Dis. 2023. PMID: 36626567 Free PMC article.
Dual Biologic or Small Molecule Therapy in Refractory Pediatric Inflammatory Bowel Disease (DOUBLE-PIBD): A Multicenter Study from the Pediatric IBD Porto Group of ESPGHAN.
Yerushalmy-Feler A, Olbjorn C, Kolho KL, Aloi M, Musto F, Martin-de-Carpi J, Lozano-Ruf A, Yogev D, Matar M, Scarallo L, Bramuzzo M, de Ridder L, Kang B, Norden C, Wilson DC, Tzivinikos C, Turner D, Cohen S. Yerushalmy-Feler A, et al. Inflamm Bowel Dis. 2024 Feb 1;30(2):159-166. doi: 10.1093/ibd/izad064. Inflamm Bowel Dis. 2024. PMID: 37042978
Deep Dive Into MicroRNAs in Inflammatory Bowel Disease.
Alfaifi J, Germain A, Heba AC, Arnone D, Gailly L, Ndiaye NC, Viennois E, Caron B, Peyrin-Biroulet L, Dreumont N. Alfaifi J, et al. Inflamm Bowel Dis. 2023 Jun 1;29(6):986-999. doi: 10.1093/ibd/izac250. Inflamm Bowel Dis. 2023. PMID: 36545755 Review.
Molecular and Functional Characterization of Human Intestinal Organoids and Monolayers for Modeling Epithelial Barrier.
Jelinsky SA, Derksen M, Bauman E, Verissimo CS, van Dooremalen WTM, Roos JL, Higuera Barón C, Caballero-Franco C, Johnson BG, Rooks MG, Pott J, Oldenburg B, Vries RGJ, Boj SF, Kasaian MT, Pourfarzad F, Rosadini CV. Jelinsky SA, et al. Inflamm Bowel Dis. 2023 Feb 1;29(2):195-206. doi: 10.1093/ibd/izac212. Inflamm Bowel Dis. 2023. PMID: 36356046 Free PMC article.
7,119 results